Search results
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters via AOL· 14 minutes agoPatrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman Sachs healthcare...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 4 days agoOzempic is a GLP-1 medication approved by the FDA for treating Type 2 diabetes. "It is a brand name...
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Investor's Business Daily· 45 minutes agoThough Stelo is designed for people with diabetes, the over-the-counter availability almost...
Obesity: Does eating chili peppers increase or decrease risk?
Medical News Today· 1 day agoChili peppers are often recognized for their slight fat-burning and metabolism-boosting properties....
Economic development in sub-Saharan Africa is linked to increasing obesity rates in women
Medical Xpress· 6 hours agoThe increasing prevalence of obesity can be attributed to rising incomes, increasingly sedentary lifestyles, the adoption of western cultures and the consumption of processed ...
Wait—Why Am I Not Losing Weight on Ozempic?
Parade· 10 hours agoOzempic is technically for the management of type 2 diabetes. The most significant "side effect" of the diabetes drug, weight loss, has made it sought...
Ozempic, Wegovy May Protect Kidney Health, New Research Finds
Health via Yahoo News· 5 hours agoOzempic and Wegovy may be able to significantly reduce the risk of kidney complications, heart...
'American Idol' alum Mandisa died from complications of class III obesity. Here's what that means.
Yahoo Life· 5 days agoHowever, an individual’s risk of developing cardiometabolic diseases like hypertension, stroke and ...
'American Idol' singer Mandisa died of class III obesity, autopsy reveals
NBC NEWS· 5 days agoGrammy-award winning gospel singer Mandisa died of complications of class III obesity, according to...
Analyst Report: Novo Nordisk
Argus Research via Yahoo Finance· 10 hours agoNovo Nordisk is a pharmaceutical company based in Denmark. Its key divisions include Diabetes Care, Obesity Care, and Rare Diseases. Key products include ...